General

Diagnostic work up of autoimmune neurological conditions 3:13
Diagnostic work up of autoimmune neurological conditions
Divyanshu Dubey • 12 Apr 2022
Developments in the NINDS network for treating ultra-rare neurological diseases 4:47
Developments in the NINDS network for treating ultra-rare neurological diseases
Nina Schor • 4 Apr 2022
Mechanisms and triggers of autoimmune neurological conditions 3:35
Mechanisms and triggers of autoimmune neurological conditions
Divyanshu Dubey • 12 Apr 2022
Immunotherapy strategies for autoimmune disorders of the nervous system 1:43
Immunotherapy strategies for autoimmune disorders of the nervous system
Divyanshu Dubey • 12 Apr 2022
Dedicated clinical training in autoimmune neurology 1:55
Dedicated clinical training in autoimmune neurology
Divyanshu Dubey • 12 Apr 2022
Prognostic and predictive biomarkers for long COVID 2:26
Prognostic and predictive biomarkers for long COVID
Jennifer Frontera • 3 Apr 2022
Racial disparities among patients with NMOSD 1:46
Racial disparities among patients with NMOSD
Mirla Avila • 12 Apr 2022
Issues noted in the care of people with IDD in Ukraine 17:37
Issues noted in the care of people with IDD in Ukraine
Seth Keller • 1 Aug 2022
Deinstitutionalization of people with IDD in Ukraine: action plans 4:51
Deinstitutionalization of people with IDD in Ukraine: action plans
Seth Keller • 1 Aug 2022
The AAN Ukraine Crisis Response Work Group 1:13
The AAN Ukraine Crisis Response Work Group
Seth Keller • 1 Aug 2022
Care of people with IDD in Ukraine: why act now? 6:39
Care of people with IDD in Ukraine: why act now?
Seth Keller • 1 Aug 2022
PAREA: psychedelic-assisted therapies in Europe 6:12
PAREA: psychedelic-assisted therapies in Europe
Tadeusz Hawrot • 26 Jun 2022
Austria’s historical contribution to neurology 1:24
Austria’s historical contribution to neurology
Hans Lassmann • 27 Jun 2022
The promise of psychedelic-assisted therapies 5:10
The promise of psychedelic-assisted therapies
Tadeusz Hawrot • 26 Jun 2022
Ongoing trials investigating psychedelic-assisted therapies 1:41
Ongoing trials investigating psychedelic-assisted therapies
Tadeusz Hawrot • 26 Jun 2022
Making neurological disorders a major global health priority 4:23
Making neurological disorders a major global health priority
Tadeusz Hawrot • 26 Jun 2022
The content of VJNeurology is intended for healthcare professionals